BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Flahou C, Morishima T, Takizawa H, Sugimoto N. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. Front Immunol 2021;12:662360. [PMID: 33897711 DOI: 10.3389/fimmu.2021.662360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Dahlke J, Schott JW, Vollmer Barbosa P, Klatt D, Selich A, Lachmann N, Morgan M, Moritz T, Schambach A. Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants. J Pers Med 2021;11:565. [PMID: 34204193 DOI: 10.3390/jpm11060565] [Reference Citation Analysis]
3 Samandari M, Quint J, Rodríguez-delaRosa A, Sinha I, Pourquié O, Tamayol A. Bioinks and Bioprinting Strategies for Skeletal Muscle Tissue Engineering. Adv Mater 2022;34:e2105883. [PMID: 34773667 DOI: 10.1002/adma.202105883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Carvalho AM, Nunes R, Sarmento B. From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment. European Journal of Pharmaceutical Sciences 2022;172:106148. [DOI: 10.1016/j.ejps.2022.106148] [Reference Citation Analysis]
5 Arzi B, Webb TL, Koch TG, Volk SW, Betts DH, Watts A, Goodrich L, Kallos MS, Kol A. Cell Therapy in Veterinary Medicine as a Proof-of-Concept for Human Therapies: Perspectives From the North American Veterinary Regenerative Medicine Association. Front Vet Sci 2021;8:779109. [DOI: 10.3389/fvets.2021.779109] [Reference Citation Analysis]
6 Dimitri A, Herbst F, Fraietta JA. Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing. Mol Cancer 2022;21:78. [PMID: 35303871 DOI: 10.1186/s12943-022-01559-z] [Reference Citation Analysis]
7 Okutani Y, Abe K, Yamashita A, Morioka M, Matsuda S, Tsumaki N. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface. Tissue Eng Part A 2021. [PMID: 34182799 DOI: 10.1089/ten.TEA.2021.0053] [Reference Citation Analysis]
8 Głowacki P, Rieske P. Application and Design of Switches Used in CAR. Cells 2022;11:1910. [PMID: 35741039 DOI: 10.3390/cells11121910] [Reference Citation Analysis]